Delivery Order 36F79720D0189-36C26124N0283
Award Date 11/29/23
Potential Completion Date 1/29/24
Potential Value $13K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Wilmington, DE 19803, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $12,873.68 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract to Incyte Corporation. The firm fixed price order is for the provision of PEMIGATINIB (PEMAZYRE) 4.5MG tablets to the VA medical center located in Talleyville, Delaware, with performance taking place from July 28, 2023 through September 28, 2023. As the prime contractor, Incyte will...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $12,725 delivery order against Incyte Corporation's Pharmaceuticals and Drugs GSA Schedule contract number FSS-61-IB. This firm fixed price order is to provide PEMIGATINIB/PEMAZYRE 4.5MG tablets for use in VA's healthcare programs from November 3rd to December 4th, 2023. Place of performance will be Incyte's facility in Talleyville, Delaware. No subcontractors or set aside...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 21 to Incyte Corporation, a global biopharmaceutical company. The $13,290.97 delivery order contract is for the drug Pemigatinib, which is used to treat certain types of cancer. The contract was awarded under Incyte's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA, and has a firm fixed price. No set-aside...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded Incyte Corporation a $12,873.68 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract to provide PEMIGATINIB/PEMAZYRE 4.5MG tablets. The order was awarded on May 2, 2023 with a completion date of June 2, 2023 and utilizes firm fixed pricing. Performance will take place in Talleyville, Delaware. No set-aside designation was applied to this order to...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded Incyte Corporation a $12,725.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract to provide 13.5mg tabs of pemigatinib (Pemazyre). Performance will occur in Talleyville, Delaware by the fixed price completion date of November 15, 2020. The delivery order was awarded on October 29, 2020 with no set-aside designation specified. Pemazyre will be...
- This delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule, awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21, is for the emergency provision of 4.5mg Pemigatinib tablets to treat eligible veterans. The $12,725.23 firm fixed price contract was awarded on June 13, 2023 to Incyte Corporation of Talleyville, Delaware and has a period of performance through July 13, 2023. No set-aside designation was applied...
- Incyte Corporation was awarded a $12,725.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The firm fixed price order is for the drug PEMAZYRE and has a completion date of December 31, 2020. The contract was awarded on November 18, 2020 and utilizes Master Schedule contract FSS-61-IB, which provides pharmaceuticals and drugs to government agencies. The...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $12,725.23 delivery order to Incyte Corporation under the company's Pharmaceuticals and Drugs GSA Schedule contract. The delivery order is for PEMAZYRE/PEMIGATINIB 4.5MG tablets, to be delivered to a location in Talleyville, Delaware between September 25, 2023 and November 10, 2023. The contract has a firm fixed price and will provide cancer treatment medications to support VHA...
- The Department of Veterans Affairs Veterans Health Administration awarded Incyte Corporation a $556.97 million firm fixed price delivery order against their Pharmaceuticals and Drugs GSA Schedule contract. This order is to provide PEMAZYRE 9MG tablets to VHA facilities in Veterans Integrated Service Network 15. The place of performance is Incyte's location in Talleyville, Delaware and the period of performance runs from November 2020 through November 2021. No set aside designation or...
- This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 21 of the U.S. Department of Veterans Affairs (VA) to Incyte Corporation for the supply of the pharmaceutical drug Pemigatinib, marketed as Pemazyre. The $119,618.73 contract provides for the delivery of this anti-cancer medication to VA medical facilities across the country to support healthcare services for eligible veterans. Incyte, a global biopharmaceutical company, holds two major contract...